Grassley Asks FDA About Charging For Foreign Drug Inspections
This article was originally published in The Gold Sheet
Executive Summary
Sen. Charles Grassley (R-Iowa), the leading Republican on the Senate Finance Committee, wants to follow up with FDA regarding the idea of charging for foreign drug manufacturing inspections, which surfaced during an FDA briefing of his staff in August, he said in an Oct. 30 letter to FDA Commissioner Andrew von Eschenbach.